By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Enanta Pharmaceuticals, Inc. Announces European Commission (EC) Grants Marketing Authorizations For AbbVie (ABBV)’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets)... 1/16/2015 9:50:01 AM
Enanta Pharmaceuticals, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 9:53:46 AM
Enanta Pharmaceuticals, Inc. Announces FDA Approves AbbVie (ABBV)’s VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) For The Treatment Of Chronic Genotype 1 Hepatitis C Virus 12/22/2014 12:13:55 PM
Enanta Pharmaceuticals, Inc. Added To The NASDAQ Biotechnology Index 12/15/2014 11:36:51 AM
Enanta Pharmaceuticals, Inc. Added To The NASDAQ Biotechnology Index 12/15/2014 10:21:19 AM
Enanta Pharmaceuticals, Inc. Reports Financial Results For its Fiscal Fourth Quarter And Year Ended September 30, 2014 11/24/2014 9:52:16 AM
Enanta Pharmaceuticals, Inc. To Present At The Deutsche Bank (DB) 2014 BioFEST 11/21/2014 12:10:34 PM
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Fourth Quarter And Year Ended September 30, 2014 11/17/2014 5:27:12 PM
Enanta Pharmaceuticals, Inc. Announces Results From Phase 2b PEARL-I Study In Genotype 4 Chronic Hepatitis C Patients At The Liver Meeting 2014® 11/11/2014 11:08:43 AM
Enanta Pharmaceuticals, Inc. Announces Results From TURQUOISE-I Study In Chronic Hepatitis C Patients With HIV-1 Co-Infection And From The CORAL-I Study In Liver Transplant Recipients At The Liver Meeting 2014® 11/11/2014 10:36:10 AM
12345678
//-->